Semi-quantification of renal perfusion using


Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 27 08 2020
accepted: 09 11 2020
pubmed: 3 1 2021
medline: 15 10 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

Renal scintigraphy with In this retrospective, single-center, observational study, 86 subjects with left ventricular ejection fraction ≤ 45% and 31 age-matched subjects without HF underwent renal scintigraphy with RP in HF was impaired despite comparable GFRs between the control and HF groups. RP in HF was characterized by a longer T Renal scintigraphy with

Sections du résumé

BACKGROUND BACKGROUND
Renal scintigraphy with
METHODS METHODS
In this retrospective, single-center, observational study, 86 subjects with left ventricular ejection fraction ≤ 45% and 31 age-matched subjects without HF underwent renal scintigraphy with
RESULTS RESULTS
RP in HF was impaired despite comparable GFRs between the control and HF groups. RP in HF was characterized by a longer T
CONCLUSIONS CONCLUSIONS
Renal scintigraphy with

Identifiants

pubmed: 33386522
doi: 10.1007/s12149-020-01556-6
pii: 10.1007/s12149-020-01556-6
doi:

Substances chimiques

Radiopharmaceuticals 0
Technetium Tc 99m Pentetate VW78417PU1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-194

Subventions

Organisme : National Natural Science Foundation of China
ID : No. 81670357
Organisme : Human Resources and Social Security of Hebei Province
ID : CY201615

Références

Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61–7.
doi: 10.1016/j.jacc.2003.07.031
Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589–96.
doi: 10.1016/j.jacc.2008.05.068
Mullens W, Nijst P. Cardiac output and renal dysfunction. J Am Coll Cardiol. 2016;67(19):2209–12.
doi: 10.1016/j.jacc.2016.03.537
Zamora E, Lupon J, Vila J, et al. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas. J Am Coll Cardiol. 2012;59(19):1709–15.
doi: 10.1016/j.jacc.2011.11.066
Hanberg JS, Sury K, Wilson FP, et al. Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure. J Am Coll Cardiol. 2016;67(19):2199–208.
doi: 10.1016/j.jacc.2016.02.058
Jessup M, Costanzo MR. The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol. 2009;53(7):597–9.
doi: 10.1016/j.jacc.2008.11.012
Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 1990;39(Suppl 4):10–21 (discussion 22-14).
doi: 10.2165/00003495-199000394-00004
Kula AJ, Hanberg JS, Wilson FP, et al. Influence of titration of neurohormonal antagonists and blood pressure reduction on renal function and decongestion in decompensated heart failure. Circ Heart Fail. 2016;9(1):e002333.
doi: 10.1161/CIRCHEARTFAILURE.115.002333
Verbrugge FH, Dupont M, Steels P, et al. The kidney in congestive heart failure: “are natriuresis, sodium, and diuretics really the good, the bad and the ugly?” Eur J Heart Fail. 2014;16(2):133–42.
doi: 10.1002/ejhf.35
Afsar B, Ortiz A, Covic A, Solak Y, Goldsmith D, Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016;9(1):39–47.
doi: 10.1093/ckj/sfv124
Tang WH, Kitai T. Intrarenal Venous Flow: A Window Into the Congestive Kidney Failure Phenotype of Heart Failure? JACC Heart failure. 2016;4(8):683–6.
doi: 10.1016/j.jchf.2016.05.009
Murray AW, Barnfield MC, Waller ML, Telford T, Peters AM. Assessment of glomerular filtration rate measurement with plasma sampling: a technical review. J Nucl Med Technoly. 2013;41(2):67–75.
doi: 10.2967/jnmt.113.121004
Taylor AT. Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications. J Nucl Med. 2014;55(5):786–98.
doi: 10.2967/jnumed.113.133454
Yazici B, Oral A, Gokalp C, Akgun A, Toz H, Hoscoskun C. A new quantitative index for baseline renal transplant scintigraphy with 99mTc-DTPA in evaluation of delayed graft function and prediction of 1-year graft function. Clin Nucl Med. 2016;41(3):182–8.
doi: 10.1097/RLU.0000000000001020
Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. J Nucl Med. 1996;37(11):1876–82.
pubmed: 8917196
O’Reilly PH. Standardization of the renogram technique for investigating the dilated upper urinary tract and assessing the results of surgery. BJU Int. 2003;91(3):239–43.
doi: 10.1046/j.1464-410X.2003.04050.x
Taylor AT, Blaufox MD, De Palma D, et al. Guidance document for structured reporting of diuresis renography. Semin Nucl Med. 2012;42(1):41–8.
doi: 10.1053/j.semnuclmed.2010.12.006
Gates G. Computation of glomerular filtration rate with Tc-99m DTPA: an in-house computer program. J Nucl Med. 1984;25:613–8.
pubmed: 6374072
el Maghraby TA, van Eck-Smit BL, de Fijter JW, Pauwels EK. Quantitative scintigraphic parameters for the assessment of renal transplant patients. Eur J Radiol. 1998;28(3):256–69.
doi: 10.1016/S0720-048X(97)00179-4
Damman K, Testani JM. The kidney in heart failure: an update. Eur Heart J. 2015;36(23):1437–44.
doi: 10.1093/eurheartj/ehv010
Schrier RW, Shchekochikhin D. Assessment of renal function in heart failure. J Am Coll Cardiol. 2012;59(19):1716–8.
doi: 10.1016/j.jacc.2011.12.041
Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102(2):203–10.
doi: 10.1161/01.CIR.102.2.203
Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671–8.
doi: 10.1161/CIRCULATIONAHA.105.580506
Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47(10):1987–96.
doi: 10.1016/j.jacc.2005.11.084
Carmines PKIE, Gensure RC. Arterial pressure effects on pre- glomerular microvasculature of juxtamedullary nephrons. Am J Physiol Heart Circ Physiol. 1990;258:F94–102.
doi: 10.1152/ajprenal.1990.258.1.F94
Thomson SC, Blantz RC. Glomerulotubular balance, tubuloglomerular feedback, and salt homeostasis. J Am Soc Nephrol. 2008;19(12):2272–5.
doi: 10.1681/ASN.2007121326
Smilde TDJ, Damman K, van der Harst P, et al. Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol. 2008;98(2):121–9.
doi: 10.1007/s00392-008-0732-z
Testani JM, Cappola TP, Shen J, Shannon RP, Kimmel SE. Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes: an application of the escape trial limited dataset. J Am Coll Cardiol. 2011;57(14):E305.
doi: 10.1016/S0735-1097(11)60305-7
Lipcsey M, Bellomo R. Septic acute kidney injury: hemodynamic syndrome, inflammatory disorder, or both? Crit Care. 2011;15(6):1008.
doi: 10.1186/cc10525
Pallone TLSE, Turner MR. Intrarenal blood flow_ microvascular anatomy and the regulation of medullary perfusion. Clin Exp Pharmacol Physiol. 1998;25(6):383–92.
doi: 10.1111/j.1440-1681.1998.tb02220.x
Nissen OI. The filtration fractions of plasma supplying the superficial and deep venous drainage area of the gat kidney. Acta Physiol Scand. 1966;68(3–4):275–85.
doi: 10.1111/j.1748-1716.1966.tb03428.x
Dupont M, Mullens W, Finucan M, Taylor DO, Starling RC, Tang WH. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail. 2013;15(4):433–40.
doi: 10.1093/eurjhf/hfs209
Metra M, Ponikowski P, Cotter G, et al. Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF. Eur Heart J. 2013;34(40):3128–36.
doi: 10.1093/eurheartj/eht371
Voors AA, Dahlke M, Meyer S, et al. Renal hemodynamic effects of serelaxin in patients with chronic heart failure: a randomized, placebo-controlled study. Circ Heart Fail. 2014;7(6):994–1002.
doi: 10.1161/CIRCHEARTFAILURE.114.001536
Preston DFLR. Radionuclide evaluation of renal transplants. J Nucl Med. 1979;20:1094–6.
Hamilton D, Miola UJ, Payne MC. The renal transplant perfusion index: reduction in the error and variability. Eur J Nucl Med. 1994;21(3):232–8.
doi: 10.1007/BF00188672
El-Maghraby TAF, de Fijter JW, van Eck-Smit BLF, Zwinderman AH, El-Haddad SI, Pauwels EKJ. Renographic indices for evaluation of changes in graft function. Eur J Nucl Med. 1998;25:1575–86.
doi: 10.1007/s002590050338
Dubovsky EV, Russell CD, Yester MV, Thorstad BL, Ryan JP. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants? Contrib Nephrol. 1990;79:118–22.
doi: 10.1159/000418162
Erbas B, Tuncel M. Renal function assessment during peptide receptor radionuclide therapy. Semin Nucl Med. 2016;46(5):462–78.
doi: 10.1053/j.semnuclmed.2016.04.006
Schneider AG, Goodwin MD, Bellomo R. Measurement of kidney perfusion in critically ill patients. Crit Care. 2013;17(2):220.
doi: 10.1186/cc12529

Auteurs

Haifang Ma (H)

Heart Failure Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang City, 050031, Hebei Province, China.
Cardiovascular Research Center of Hebei Medical University, Shijiazhuang City, Hebei Province, China.

Xian Gao (X)

Health Institute of The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China.

Pei Yin (P)

Division of Nuclear Medicine, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China.

Qingzhen Zhao (Q)

Heart Failure Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang City, 050031, Hebei Province, China.

Yuzhi Zhen (Y)

Heart Failure Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang City, 050031, Hebei Province, China.

Yu Wang (Y)

Heart Failure Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang City, 050031, Hebei Province, China.

Kunshen Liu (K)

Heart Failure Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang City, 050031, Hebei Province, China.

Chao Liu (C)

Heart Failure Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang City, 050031, Hebei Province, China. dr.liuchao@gmail.com.
Cardiovascular Research Center of Hebei Medical University, Shijiazhuang City, Hebei Province, China. dr.liuchao@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH